inflammatory lesions

Related by string. * Inflammatory : inflammatory abusive derogatory . inflammatory arthritis . inflammatory bowel disease . pelvic inflammatory disease . inflammatory rhetoric . Inflammatory Bowel Disease / Lesions . Lesion . lesioned : target lesion revascularization . metastatic lesions . benign lesions . pigmented lesions rejuvenate . precursor lesions . pigmented lesions * *

Related by context. All words. (Click for frequent words.) 67 T2 lesions 67 nephrotoxicity 66 timepoint 66 thromboembolic events 66 neointimal 65 AK lesions 65 Crohn Disease Activity 65 Psoriasis Area 65 PASI scores 65 osteosarcomas 65 acne lesions 64 pruritus itching 64 chlorambucil 64 metastatic lesions 64 incontinence episodes 64 gadolinium enhancing lesions 64 serum phosphate levels 64 intravitreal injections 64 histologically 64 Angioedema 64 conjunctival hyperemia 64 T2 lesion volume 64 transaminases 64 liver histology 64 CIMZIA ™ 64 hematologic toxicity 64 lumbar spine BMD 63 hypercalcemia 63 anterior uveitis 63 eosinophil count 63 ibandronate 63 flutamide 63 oxycodone CR 63 solifenacin 63 octreotide LAR 63 alanine aminotransferase ALT 63 HBeAg seroconversion 63 tolvaptan 63 hypomagnesemia 63 virologic response 63 hip BMD 63 rebleeding 63 gastrointestinal toxicity 63 gout flares 63 intravascular hemolysis 63 gastric adenocarcinoma 63 teriflunomide 63 ritonavir boosted 63 periprocedural MI 63 salmeterol fluticasone 63 neovascular 63 leucopenia 63 timepoints 63 transaminase elevations 63 serum testosterone 63 PRADAXA #mg 63 serum phosphate 62 plasma uric acid 62 sUA 62 INCB# [003] 62 colorectal carcinoma 62 β blockers 62 atheroma volume 62 lesions 62 serum urate levels 62 seminomas 62 ALT elevations 62 binary restenosis 62 lymphopenia 62 infarct size 62 lichen planus 62 artery stenosis 62 dysuria 62 gastrointestinal perforation 62 adjunctive placebo 62 eosinophilia 62 serum HBV DNA 62 oral diclofenac 62 postoperative inflammation 62 rosuvastatin #mg 62 prednisone prednisolone 62 hyperplastic 62 MADRS score 62 seropositive patients 62 erythema redness 62 Durezol 62 retinal thickness 62 Toxicities 62 immunoreactivity 62 paricalcitol 62 OAB symptoms 62 upper gastrointestinal bleeding 62 epistaxis 62 serum HCV RNA 62 Hypotension 62 F FDG uptake 62 CIMZIA TM 62 serologically active patients 62 leiomyomas 62 myeloperoxidase 62 ximelagatran 62 systemic corticosteroid 62 ertapenem 62 CR nPR 62 hyperalgesia 62 telangiectasia 62 rFVIIa 61 severe exacerbations 61 lumbar spine bone 61 hyperoxaluria 61 macular thickness 61 dosage regimens 61 leukopenia 61 mg/m2 dose 61 metastatic neuroendocrine tumors 61 mcg BID 61 chronic periodontitis 61 IL 1ß 61 Elitek 61 TEAEs 61 dyspareunia 61 PSADT 61 biochemical relapse 61 mucosal healing 61 angiographic outcomes 61 plus methotrexate 61 tolterodine ER 61 lopinavir r arm 61 serum urate 61 achieved statistical significance 61 vitreous haze 61 adalimumab 61 lesional 61 serum retinol 61 pyridostigmine 61 symptomatic VTE 61 haematological toxicity 61 proctitis 61 serum calcium levels 61 CIN3 61 hyperbilirubinemia 61 CsA 61 cobiprostone 61 ALVESCO 61 NMIBC 61 renal tumors 61 tumor regressions 61 rhinorrhea 61 CIMZIA TM certolizumab pegol 61 platelet reactivity 61 ACR# responses 61 P = .# 61 sulfasalazine 61 lung metastases 61 Tumor shrinkage 61 steroid dexamethasone 61 radiochemotherapy 61 follicular lymphomas 61 isoproterenol 61 alanine aminotransferase 61 TNF Tumor Necrosis Factor 61 pulmonary metastases 61 perioperative complications 61 elevated IOP 61 FOLPI 61 hypophosphatemia 61 Flu Cy 61 serum concentrations 61 posaconazole 61 lactate dehydrogenase LDH 61 CCyR 61 salivary flow 61 CP CPPS 61 analgesic efficacy 61 extrapyramidal symptoms 61 nonvertebral fractures 61 keloid scarring 61 choroidal neovascularization 61 hyperintensity 61 morphometric vertebral fractures 60 COPD exacerbations 60 tumor xenograft models 60 neutrophil count 60 Navelbine 60 elevated ALT 60 dose dependently 60 endometrial hyperplasia 60 fibrin deposition 60 allergic airway inflammation 60 log# copies mL 60 XIENCE V PROMUS Stent 60 carotid IMT 60 administered subcutaneously 60 clodronate 60 pentoxifylline 60 serum PTH 60 seborrheic dermatitis 60 CDAI 60 coronary stenosis 60 hyperammonemia 60 ascites 60 pituitary adenomas 60 MALT lymphoma 60 antiangiogenic therapy 60 complete cytogenetic response 60 antimuscarinic 60 endophthalmitis 60 neurologic symptoms 60 HER2 amplification 60 mg kg dose 60 SVR# 60 timolol 60 aspartate aminotransferase 60 intraoperative complications 60 histologic subtype 60 basal cell cancers 60 REYATAZ r arm 60 acid regurgitation 60 LHRH agonists 60 polyposis 60 pCR 60 pruritis 60 antiandrogen 60 mitomycin C 60 elevated intraocular pressure 60 neoplastic lesions 60 cytogenetic response 60 nasal obstruction 60 tiotropium bromide 60 azacytidine 60 piperacillin tazobactam 60 brain lesions 60 receptor blocker 60 node metastases 60 tipranavir r 60 renal toxicity 60 Adverse events 60 febrile neutropenia 60 apo B 60 myopathy rhabdomyolysis 60 serum triglycerides 60 intratumoral 60 FOLPI regimen 60 PsA 60 colorectal adenoma 60 ACZ# 60 undetectable HBV DNA 60 intact parathyroid hormone 60 atrophic gastritis 60 ketoconazole 60 spontaneous bowel movements 60 incidence ≥ 60 IPSS 60 lipomas 60 neutrophil counts 60 irbesartan 60 dysmenorrhoea 60 aminotransferases 60 corticosteroid therapy 60 clomipramine 60 macroalbuminuria 60 VA# [002] 60 intravenous bisphosphonates 60 advanced adenomas 60 hepatic enzymes 60 SGPT 60 granulomatous 60 Doxil ® 60 urinary oxalate 60 alemtuzumab treated 60 locoregional recurrence 60 pimecrolimus cream 60 airway hyper responsiveness 60 FDG uptake 60 overactive bladder symptoms 60 clinically meaningful improvements 60 bullous 60 arthralgias 60 adenoma 60 etanercept 60 neutropaenia 60 Febrile neutropenia 60 #mg BID [001] 60 aspartate aminotransferase AST 60 glycated hemoglobin levels 60 thrombotic events 60 leiomyoma 60 transaminase 60 antitumor efficacy 60 prostate cancer CaP 60 biochemical recurrence 60 renal cell carcinomas 60 evaluable subjects 60 NPH insulin 60 4mg/kg 60 hypertrophic scars 60 EDSS scores 60 clinically meaningful reductions 60 elevated LDH 60 hyperintense lesions 60 basal cell carcinoma BCC 60 INC# 60 pericardial effusion 60 proliferative diabetic retinopathy 60 CDI recurrence 60 tapentadol ER 60 detrusor overactivity 60 adalimumab Humira 60 cytopenias 60 thromboembolic 60 hemorrhagic complications 60 hepatic encephalopathy HE 60 bone metastasis 60 APTIVUS r 60 bacteriuria 60 splenectomized patients 60 generalized seizures 60 rizatriptan 60 systemic absorption 60 PROMACTA 60 mycophenolate mofetil 60 KRAS mutations occur 60 fluorouracil leucovorin 60 FluCAM arm 60 paraprotein 59 leukemia AML 59 Pemetrexed 59 papillomas 59 breast carcinomas 59 P. acnes 59 biologic DMARD 59 DLTs 59 plasminogen activators 59 intima media thickness 59 hypopigmentation 59 LEXIVA r 59 hematological toxicity 59 tacrolimus ointment 59 TNFalpha 59 viral titers 59 carcinoids 59 invasive candidiasis 59 eplerenone 59 stomatitis 59 5-FU/LV 59 SSc 59 BPH benign prostatic 59 acne vulgaris 59 secondary efficacy endpoint 59 variceal 59 NIH CPSI 59 HbA 1c levels 59 IFN α 59 MAXALT 59 vesicoureteral reflux 59 Prostatitis 59 adenocarcinomas 59 8mg/kg 59 lymphadenopathy 59 serum aminotransferase levels 59 hepatocellular 59 detrusor 59 virologic breakthrough 59 DOXIL 59 Natalizumab 59 FOLFIRI 59 airway hyperresponsiveness 59 endometrial carcinoma 59 bosentan 59 fluconazole resistant 59 microglial activation 59 bothersome symptom 59 breast carcinoma 59 baseline HbA1c 59 urothelial 59 histologic subtypes 59 ULORIC 59 sonographically 59 lactate dehydrogenase 59 airflow obstruction 59 Index CDAI 59 decitabine 59 skeletal metastases 59 SPIRIVA ® 59 PSA nadir 59 malignant lesions 59 alkylating agent 59 Thal Dex 59 FASLODEX 59 highly emetogenic 59 Hypercholesterolemia 59 mucosal inflammation 59 laxation 59 recurrent VTE 59 sustained virologic response 59 polypoid 59 squamous 59 liver metastasis 59 HGPIN 59 bezafibrate 59 serum creatinine levels 59 angiotensin converting enzyme inhibitors 59 BENICAR HCT 59 extracranial 59 vitreous floaters 59 intracranial hemorrhage ICH 59 bone marrow suppression 59 neointimal hyperplasia 59 calculi 59 cinacalcet 59 Estradiol 59 icatibant 59 myelosuppression 59 corticosteroid dose 59 amyloid deposition 59 alteplase 59 FOSRENOL ® 59 gout flare 59 enalapril 59 cirrhotic 59 zoledronate 59 Ophena TM 59 radiotherapy RT 59 intravitreal injection 59 neovascularization 59 nonalcoholic steatohepatitis NASH 59 mg QD 59 triamcinolone 59 plasma concentrations 59 annualized relapse 59 oropharyngeal 59 candidemia 59 HBeAg negative 59 aminotransferase levels 59 pseudoaneurysm 59 epithelial tumors 59 vWF 59 serum prostate 59 C Reactive Protein 59 CK # plasma concentrations 59 zolmitriptan 59 nondiabetic patients 59 abacavir lamivudine 59 neurologic progression 59 acarbose 59 pheochromocytoma 59 certolizumab 59 PEGylated anti 59 ABC/3TC 59 HBeAg positive patients 59 VAPRISOL 59 solar keratoses 59 relapsed MM 59 hypokalemia 59 TMP SMX 59 vasodilatation 59 unresectable tumors 59 adriamycin 59 lopinavir r 59 splenic 59 comedones 59 urothelial carcinoma 59 FOLFOX4 59 ZOLINZA 59 denervation 59 achieved PASI 59 adenoma recurrence 59 parathyroid hormone PTH 59 TNF α 59 μmol L 59 variceal bleeding 59 plasma HCV RNA 59 sweat chloride 59 ruboxistaurin 59 NAbs 59 nodal metastasis 59 BARACLUDE ® 59 caspofungin 59 Vidofludimus 59 discontinuations due 59 KAPIDEX 59 mcg QD 59 Pred Forte 59 HBeAg 59 BoNTA 59 reflux esophagitis 59 serum phosphorus 59 platelet inhibition 59 Tiotropium 59 HMG CoA reductase inhibitors 59 Subgroup analysis 59 PAOD 59 definite stent thrombosis 59 teriparatide 59 Combination therapy 59 CIPN 59 inflammatory acne 59 osteoporotic vertebral compression fractures 59 dosing frequency 59 RAPAFLO R 59 abdominal distension 59 oxcarbazepine 59 QD dosing 59 explants 59 microvessel density 59 fluvastatin 59 gadolinium enhanced 59 hypertrophic scarring 59 Barrett esophagus BE 59 ACTEMRA TM 59 oral allopurinol 59 antiemetics 59 symptomatic intracranial 59 #mg/day [002] 59 tigecycline 59 imiquimod cream 59 dysmenorrhea 58 docetaxel Taxotere ® 58 glycosylated hemoglobin HbA1c 58 verteporfin 58 myelosuppressive 58 stent restenosis 58 chlorthalidone 58 nicardipine 58 hematologic parameters 58 rotigotine 58 EDARBI 58 vasospasm 58 hepatotoxicity 58 parenchymal 58 tamsulosin 58 cisplatin vinorelbine 58 mTOR inhibitors 58 Severity Index PASI 58 Postoperative complications 58 mL/min/#.# m 2 58 fluticasone salmeterol 58 severe neutropenia 58 dose limiting toxicities 58 upper GI tract 58 radiographic progression 58 Chronic Prostatitis 58 GI motility 58 serum calcium 58 ACR# ACR# 58 lipid parameters 58 choroidal 58 5FU 58 B7 H3 58 myeloproliferative diseases 58 atazanavir ritonavir 58 CHOP chemotherapy 58 macrophage infiltration 58 cystoid macular edema 58 hyperphenylalaninemia HPA due 58 metastatic malignant 58 Teriflunomide 58 carotid plaque 58 interferon beta therapy 58 postsurgical pain 58 voriconazole 58 alicaforsen enema 58 efalizumab 58 azelaic acid 58 recurrent venous thromboembolism 58 proteinuria 58 nanomolar 58 reinfarction 58 choroidal neovascularization CNV 58 neutropenic patients 58 erythema 58 superficial basal cell carcinoma 58 #.#/#.# mmHg [001] 58 partial remissions 58 μg ml 58 recurrent glioblastoma multiforme 58 elastase 58 subependymal giant cell 58 oral rivaroxaban 58 hyperkalemia 58 angiographically 58 demonstrated antitumor activity 58 CYT# potent vascular disrupting 58 IFN beta 58 perfusion defects 58 Histologically 58 hepatic metastases 58 lenalidomide dexamethasone 58 keloid 58 aortic insufficiency 58 moderate renal impairment 58 metaplasia 58 GnRH agonists 58 XIENCE V demonstrated 58 #mg/day [001] 58 Hepatotoxicity 58 isoprostane 58 CDAI score 58 ACR# response 58 fasting plasma glucose 58 IV bisphosphonates 58 hemoptysis 58 leukocytosis 58 hyperkeratotic 58 graft occlusion 58 SGOT 58 serum cortisol 58 pleomorphic 58 paragangliomas 58 nonmelanoma skin cancers 58 mycophenolate mofetil MMF 58 F FDG PET 58 HBV DNA 58 SUVmax 58 ADPKD 58 intravesical 58 invasive ductal 58 hypercalcaemia 58 glucuronide 58 zonisamide SR 58 Target Lesion Revascularization TLR 58 nonfatal MI 58 fibrinolytic 58 Interferon alpha 58 bone resorption 58 nasal symptoms 58 vestibular schwannomas 58 miconazole 58 HbA 1c 58 -#.# mg dL [001] 58 intraocular inflammation 58 T1DM 58 Darusentan 58 gadolinium enhancing 58 macrovascular events 58 chemoradiation therapy 58 plasma urate 58 detectable HCV RNA 58 calcitonin 58 lymphocyte counts 58 gastrointestinal stromal tumors GIST 58 HBeAg positive 58 fosbretabulin 58 intravenous dosing 58 parasitemia 58 apolipoprotein B 58 elevated transaminases 58 ketorolac 58 MACCE 58 haematologic 58 granisetron 58 desvenlafaxine succinate 58 micafungin 58 LV dysfunction 58 VELCADE melphalan 58 thyroid carcinoma 58 allodynia 58 peritumoral 58 ropivacaine 58 MCyR 58 somatostatin analog 58 mg BID 58 antiandrogens 58 daunorubicin 58 androgen blockade 58 HER2 expression 58 trastuzumab Herceptin ® 58 canakinumab 58 triiodothyronine 58 AST ALT 58 laboratory abnormalities 58 postoperative complication 58 hypoglycemic events 58 fluorouracil 58 paresthesias 58 NOXAFIL 58 glycated hemoglobin HbA1c 58 hypocalcemia 58 EXJADE 58 #mmHg [001] 58 Traficet EN 58 fluticasone furoate 58 IOP lowering 58 superficial bladder cancer 58 DFMO 58 gouty arthritis 58 acute GvHD 58 mitomycin 58 necrotic core 58 #mg dose [001] 58 LY# [003] 58 severe hypersensitivity reactions 58 ATACAND 58 albumin excretion rate 58 neoplasm 58 mRNA expression 58 ischemic cardiomyopathy 58 phosphorylated tau 58 ALT flares 58 dosed orally 58 Mg Uk 58 papillary thyroid carcinoma 58 lymphocytosis 58 Eltrombopag 58 IELT 58 lumbar disc herniation 58 esophagogastric junction 58 histologically proven 58 LT NS# 58 paroxysmal AF 58 retinal vein occlusion 58 Duodenal 58 pericardial effusions 58 recurrent genital herpes 58 Erythropoietic therapies may 58 alefacept 58 xerostomia 58 oral thrush 58 CRVO 58 idraparinux 58 viral titer 58 tumor shrinkage 58 intestinal metaplasia 58 COPD exacerbation 58 Nilotinib 58 entecavir 58 carcinoid 58 rCBF 58 androgen suppression 58 octreotide 58 S aureus 58 anticholinergics 58 log# reduction 58 Cmax 58 briakinumab 58 papules 58 coronary stenoses 58 vertebral fracture 58 protein excretion 58 osteoblastic 58 estramustine 58 serum CRP 58 oral ibandronate 58 infarctions 58 leukocyte count 58 PRADAXA 58 HbA1c levels 58 ecchymosis 58 varices 58 Venous thromboembolism 58 delayed CINV 58 lumbar disk herniation 58 brain parenchyma 58 blood Phe levels 58 dexamethasone Decadron 58 HCV RNA 58 ventricular tachyarrhythmia 58 clinically meaningful improvement 58 LUTS 58 reflux disease GERD 58 fosamprenavir 58 AGILECT ® 57 EGFRIs 57 lung fibrosis 57 lung metastasis 57 proton MR spectroscopy 57 olmesartan 57 serum uric acid 57 prucalopride 57 complete cytogenetic 57 rt PA 57 norethindrone 57 atrophic 57 nodular 57 chronic prostatitis 57 postoperative mortality 57 thrombocytosis 57 urinary N telopeptide 57 lipoatrophy 57 interferon alfa 57 Retinoic Acid 57 triglyceride concentrations 57 saline placebo 57 biopsy specimen 57 mesenteric 57 HepG2 cells 57 blood Phe 57 HIV HCV coinfected 57 posttransplant 57 dysmotility 57 intranasal corticosteroid 57 antiarrhythmic 57 angiographic restenosis 57 subtrochanteric 57 CMV infection 57 mutated KRAS 57 erythropoietic 57 periocular 57 Heavy menstrual bleeding 57 systolic dysfunction 57 arterial thromboembolic events 57 ischemic lesions 57 intraocular pressure IOP 57 tipranavir 57 elagolix 57 DAVANAT 57 pegylated liposomal doxorubicin 57 selegiline 57 GISTs 57 LHRH analogues 57 diarrhea nausea fatigue 57 RAPAFLO 57 pulmonary arterial 57 aminotransferase 57 inducible nitric oxide synthase 57 goserelin 57 hepatic 57 PEGylated interferon beta 1a 57 T2DM 57 purpura 57 transdermal estradiol 57 Bosentan 57 myocardial ischemia 57 atrioventricular block 57 conjunctival 57 bimatoprost 57 duodenal ulcers 57 uveal melanoma 57 endoleaks 57 blepharitis 57 oral prodrug 57 diameter stenosis 57 metastatic malignant melanoma 57 FOLFIRI alone 57 Candida infection 57 lesion 57 hematological parameters 57 tumor necrosis 57 draining enterocutaneous 57 bacterial prostatitis 57 metabolic parameters 57 chloride secretion 57 COPAXONE R 57 PCa 57 pressor response 57 cutaneous lesions 57 pouchitis 57 tracer uptake 57 antitumor activity 57 axillary lymph nodes 57 microbleeds 57 E selectin 57 subcutaneous injections 57 thyrotropin 57 K ras mutations 57 mcg kg 57 dexrazoxane 57 Sjögren syndrome 57 peripheral sensory neuropathy 57 EGFr 57 aminotransferase elevations greater 57 acromegalic patients 57 Papillary 57 preoperatively 57 CLL SLL 57 plus medroxyprogesterone acetate 57 injected subcutaneously 57 levodopa therapy 57 rosuvastatin Crestor 57 Posaconazole 57 cardiac dysfunction 57 transaminase levels 57 vidofludimus 57 dacarbazine 57 heterotopic ossification 57 abdominal adiposity 57 proteoglycan 57 subretinal fluid 57 bronchoalveolar lavage 57 % CI #.#-#.# [007] 57 ADHF 57 paclitaxel eluting stents 57 actinic keratoses 57 ALA PDT 57 leukocyte infiltration 57 ALT normalization 57 Pharmacokinetic studies 57 selective modulator 57 hypertensives 57 pruritus 57 urge urinary incontinence 57 subscore 57 thrombocytopenic patients 57 IGFBP 3 57 sensory neuropathy 57 headache nasopharyngitis 57 Non inferiority 57 5 HT2C receptor 57 adrenal insufficiency 57 posttreatment 57 receiving golimumab 57 serum testosterone levels 57 androgen deprivation 57 gastroduodenal 57 endotoxemia 57 HbF 57 Fibrates 57 events AEs 57 EBRT 57 rHuPH# 57 posterior vitreous detachment 57 subcutaneous dose 57 BENICAR 57 nasal polyps 57 schwannomas 57 tegaserod 57 Raynaud phenomenon 57 pamidronate 57 Scale EDSS 57 cardiac toxicity 57 platelet aggregation 57 ARCALYST ® 57 progression TTP 57 QTcF 57 suppurative 57 intraperitoneal 57 ulceration 57 lispro 57 MGd 57 Periodontitis 57 REYATAZ r 57 immunomodulatory agents 57 placebo dexamethasone 57 receptor subtype 57 busulfan 57 FluCAM 57 cell lymphoma CTCL 57 recurrent DVT 57 RAPTIVA 57 nadolol 57 HIV RNA 57 Neutrophil 57 TRAIL R1 57 colorectal liver metastases 57 Exacerbations 57 ipsilateral stroke 57 ziconotide 57 tumoral 57 neurologic complications 57 cutaneous 57 Fingolimod 57 ziprasidone 57 unconjugated 57 plasma kallikrein 57 glomerular filtration 57 nasal symptom 57 osteochondroma 57 serum magnesium 57 Onychomycosis 57 mediastinal 57 Fas ligand 57 urinary excretion 57 thromboembolic complications 57 cisplatin chemotherapy 57 myocardial infarctions 57 #.#mg/dL 57 antihypertensive therapy 57 hypoglycaemic episodes 57 TNF antagonist 57 thromboembolism 57 ventricular enlargement 57 histological subtype 57 hsCRP levels 57 invasive carcinomas 57 adefovir 57 adenomatous 57 carcinoid tumor 57 IFN gamma 57 airway hyperreactivity 57 hyperemia 57 enthesitis 57 androgen ablation 57 mecamylamine 57 cell carcinomas 57 Knodell necroinflammatory score 57 distensibility 57 antiproliferative effects 57 #.#g/day 57 fatigue asthenia 57 hyperhomocysteinemia 57 SCIg 57 Thrombocytopenia 57 leukoplakia 57 periprocedural 57 mitoxantrone 57 EOquin 57 fatty infiltration 57 H pylori 57 murine model

Back to home page